1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG
- 2016
- Automated grade prediction of glioma patients based on magnetic resonance imaging and a random forests approach
- 2014
- Combination of gene copy gain and epigenetic deregulation are associated with the aberrant expression of a stem cell related HOX-signature in glioblastoma
- Use of 18F-fluoromethylcholine PET in early treatment response assessment in glioblastoma patients
- 2012
- Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
- 2010
- Unusual imaging findings in a temporal lobe high-grade glioma with involvement of brainstem white matter tracts
- Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients
- Treatment and decision-making at the end of life of high-grade glioma patients